← All verdicts
Verdict

Valuation N/A

Every analyzed stock in Valuation N/A — 479 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Valuation N/A" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
BBLGW
Bone Biologics Corp
Valuation N/A
Healthcare Risk 37 · Moderate
Price$4.54
Model IV—
P/IV—
Limited data — see page
BCARU
BCARU
Valuation N/A
Risk 33 · Moderate
Price$5.16
Model IV—
P/IV—
Limited data — see page
BCARW
BCARW
Valuation N/A
Risk 29 · Moderate
Price$0.51
Model IV—
P/IV—
Limited data — see page
BCGWW
Binah Capital Group, Inc.
Valuation N/A
Financial Services Risk 33 · Moderate
Price$0.12
Model IV—
P/IV—
Market implies -50.0%/yr vs model +6.3% · below model
BCH
BANK OF CHILE
Valuation N/A
Financial Services Risk 52 · Elevated
Price$41.72
Model IV—
P/IV—
Limited data — see page
BCS
BARCLAYS PLC
Valuation N/A
Financial Services Risk 38 · Moderate
Price$26.70
Model IV—
P/IV—
Limited data — see page
BDCIU
BTC Development Corp.
Valuation N/A
Financial Services
Price$10.30
Model IV—
P/IV—
Limited data — see page
BDCIW
BTC Development Corp.
Valuation N/A
Financial Services
Price$0.43
Model IV—
P/IV—
Limited data — see page
BDRX
Biodexa Pharmaceuticals Plc
Valuation N/A
Healthcare Risk 52 · Elevated
Price$1.33
Model IV—
P/IV—
Market implies +150.0%/yr vs model +15.0% · above model
BEAGU
Bold Eagle Acquisition Corp.
Valuation N/A
Financial Services
Price$11.22
Model IV—
P/IV—
Limited data — see page
BEATW
HeartBeam, Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$0.01
Model IV—
P/IV—
Limited data — see page
BENFW
Beneficient
Valuation N/A
Financial Services Risk 33 · Moderate
Price$0.01
Model IV—
P/IV—
Market implies -30.0%/yr vs model +15.0% · below model
BFRIW
Biofrontera Inc.
Valuation N/A
Healthcare Risk 44 · Elevated
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr vs model +14.7% · below model
BHAVU
BHAV Acquisition Corp
Valuation N/A
Financial Services
Price$10.17
Model IV—
P/IV—
Limited data — see page
BIAFW
bioAffinity Technologies, Inc.
Valuation N/A
Industrials Risk 33 · Moderate
Price$0.13
Model IV—
P/IV—
Market implies +14.1%/yr vs model +15.0% · in line
BIVIW
BIOVIE INC.
Valuation N/A
Healthcare Risk 28 · Moderate
Price$0.35
Model IV—
P/IV—
Limited data — see page
BIXIU
Bitcoin Infrastructure Acquisition Corp Ltd
Valuation N/A
Financial Services
Price$10.23
Model IV—
P/IV—
Limited data — see page
BIXIW
Bitcoin Infrastructure Acquisition Corp Ltd
Valuation N/A
Financial Services
Price$0.38
Model IV—
P/IV—
Limited data — see page
BK
BK
Valuation N/A
Risk 60 · High
Price$143.98
Model IV—
P/IV—
Limited data — see page
BKHAU
Black Hawk Acquisition Corp
Valuation N/A
Healthcare Risk 35 · Moderate
Price$12.00
Model IV—
P/IV—
Limited data — see page
BLRKU
Bluerock Acquisition Corp.
Valuation N/A
Financial Services
Price$10.23
Model IV—
P/IV—
Limited data — see page
BLRKW
Bluerock Acquisition Corp.
Valuation N/A
Financial Services
Price$0.39
Model IV—
P/IV—
Limited data — see page
BLUWU
Blue Water Acquisition Corp. III
Valuation N/A
Financial Services
Price$10.50
Model IV—
P/IV—
Limited data — see page
BLUWW
Blue Water Acquisition Corp. III
Valuation N/A
Financial Services Risk 37 · Moderate
Price$0.31
Model IV—
P/IV—
Limited data — see page
BLZRU
Trailblazer Acquisition Corp.
Valuation N/A
Financial Services
Price$10.33
Model IV—
P/IV—
Limited data — see page
BLZRW
Trailblazer Acquisition Corp.
Valuation N/A
Financial Services
Price$0.31
Model IV—
P/IV—
Limited data — see page
BNTC
Benitec Biopharma Inc.
Valuation N/A
Healthcare Risk 40 · Elevated
Price$12.08
Model IV—
P/IV—
Market implies +147.0%/yr
BNZIW
BNZIW
Valuation N/A
Risk 47 · Elevated
Price$0.01
Model IV—
P/IV—
Limited data — see page
BPACU
Blueport Acquisition Ltd
Valuation N/A
Financial Services Risk 34 · Moderate
Price$10.30
Model IV—
P/IV—
Limited data — see page
BREZU
BREZU
Valuation N/A
Price$10.11
Model IV—
P/IV—
Limited data — see page
BRK-B
BERKSHIRE HATHAWAY INC
Valuation N/A
Financial Services
Price$510.37
Model IV—
P/IV—
Limited data — see page
BRRWW
ProCap Financial, Inc.
Valuation N/A
Financial Services Risk 27 · Moderate
Price$0.39
Model IV—
P/IV—
Limited data — see page
BRUNW
Boost Run Inc.
Valuation N/A
Technology Risk 41 · Elevated
Price$6.68
Model IV—
P/IV—
Limited data — see page
BSAAU
BEST SPAC I Acquisition Corp.
Valuation N/A
Consumer Defensive
Price$10.50
Model IV—
P/IV—
Limited data — see page
BSAC
BANCO SANTANDER CHILE
Valuation N/A
Financial Services Risk 52 · Elevated
Price$35.19
Model IV—
P/IV—
Limited data — see page
BTBDW
BT Brands, Inc.
Valuation N/A
Consumer Cyclical Risk 42 · Elevated
Price$0.05
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
BZFDW
BuzzFeed, Inc.
Valuation N/A
Communication Services Risk 48 · Elevated
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
CAIIU
Collective Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.09
Model IV—
P/IV—
Limited data — see page
CANG
Cango Inc.
Valuation N/A
Financial Services Risk 51 · Elevated
Price$1.83
Model IV—
P/IV—
Market implies +56.2%/yr vs model +2.8% · above model
CAPNU
Cayson Acquisition Corp
Valuation N/A
Financial Services Risk 34 · Moderate
Price$11.17
Model IV—
P/IV—
Limited data — see page
CCGWW
Cheche Group Inc.
Valuation N/A
Financial Services Risk 37 · Moderate
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr vs model +11.7% · below model
CCIIU
Cohen Circle Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.47
Model IV—
P/IV—
Limited data — see page
CCIIW
Cohen Circle Acquisition Corp. II
Valuation N/A
Financial Services
Price$0.70
Model IV—
P/IV—
Limited data — see page
CCIXU
CCIXU
Valuation N/A
Price$10.81
Model IV—
P/IV—
Limited data — see page
CCIXW
CCIXW
Valuation N/A
Price$0.00
Model IV—
P/IV—
Limited data — see page
CCXIU
Churchill Capital Corp XI
Valuation N/A
Industrials
Price$13.79
Model IV—
P/IV—
Limited data — see page
CCXIW
Churchill Capital Corp XI
Valuation N/A
Industrials
Price$5.89
Model IV—
P/IV—
Limited data — see page
CDROW
Codere Online Luxembourg, S.A.
Valuation N/A
Communication Services Risk 42 · Elevated
Price$0.58
Model IV—
P/IV—
Market implies -50.0%/yr vs model +28.2% · below model
CELUW
CELUW
Valuation N/A
Risk 66 · High
Price$0.00
Model IV—
P/IV—
Limited data — see page
CETX
CEMTREX INC
Valuation N/A
Industrials Risk 38 · Moderate
Price$2.43
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.4% · below model
CGCTU
CGCTU
Valuation N/A
Price$12.01
Model IV—
P/IV—
Limited data — see page
CGCTW
CGCTW
Valuation N/A
Price$0.75
Model IV—
P/IV—
Limited data — see page
CHARU
Charlton Aria Acquisition Corp
Valuation N/A
Financial Services
Price$10.93
Model IV—
P/IV—
Limited data — see page
CHECU
Chenghe Acquisition III Co.
Valuation N/A
Financial Services
Price$10.25
Model IV—
P/IV—
Limited data — see page
CHECW
Chenghe Acquisition III Co.
Valuation N/A
Financial Services
Price$0.12
Model IV—
P/IV—
Limited data — see page
CHPGU
ChampionsGate Acquisition Corp
Valuation N/A
Financial Services
Price$10.48
Model IV—
P/IV—
Limited data — see page
CHR
Cheer Holding, Inc.
Valuation N/A
Technology Risk 44 · Elevated
Price$1.62
Model IV—
P/IV—
Market implies -50.0%/yr vs model +7.1% · below model
CINGW
Cingulate Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$0.01
Model IV—
P/IV—
Limited data — see page
CISS
C3is Inc.
Valuation N/A
Industrials Risk 36 · Moderate
Price$1.37
Model IV—
P/IV—
Market implies -50.0%/yr vs model +12.8% · below model
CMIIU
Inflection Point Acquisition Corp. VII
Valuation N/A
Technology
Price$10.95
Model IV—
P/IV—
Limited data — see page